Our Mastery
Testimonial
- "Amazing success ratio in such uncertain market and paid service is very affordable ...Good job done by your team...keep it up guys."
-Venkat (Chennai)
Party Plot Owner - "I am trading in stock market since last 8 years; I have subscribed services from many advisory companies. Conclusion is that no one can provide 100% accuracy in this NSE market. But accuracy of intraday tips from this firm is the highest among all share tips companies" Rahul Varma (Mumbai)
Owner of an Insurance Firm - "I have taken free trial of intraday tips for 2 days and 80% call is profitable. Then I have subscribed paid membership for trading advice and now I am quite satisfied with services. Important thing is do not think more; Just trade what you are suggested" -Kevin Patel (Ahmedabad)
BDM at IT Company - "Made Good Profit in the Intraday, Jackpot Calls, F&o Tips. Overall Service is very good. Especially I like your Fast tips Sms Service & Exit Call System. Your tips have very good performance." -Manoj Arora (Delhi)
CEO of Real Estate Company
Elder Pharmaceuticals Ltd share price today (on 21 March 2023).
We Provide Best stock tips for Elder Pharmaceuticals Ltd. A1 Intraday Tips is accurate share tips Provider Company in India in Nse market. A1 Intraday Tips, also provide Daily Charts with Nse Share Market current price of Elder Pharmaceuticals Ltd with today performance in nse market. Contact Us for Jackpot Stock tips.
Get Free Stock Tips for Elder Pharmaceuticals Ltd
BSE: 532322 | NSE: ELDERPHARM | ISIN: INE975A01015 Market Cap: [Rs.Cr.] 647 | Face Value: [Rs.] 10 Industry: Pharmaceuticals - Indian - Bulk Drugs
In 1989, Mr. Jagdish Saxena sets up Elder Pharma in Mumbai. Elder Pharmaceuticals ranked as the 29th largest pharmaceutical company commenced operations in 1989. It is rated as the third fastest growing company, by revenue, in the pharmaceutical industry.
Elder Pharmaceuticals Ltd is one of the fastest growing pharmaceutical companies in India. The company's principal activities include the manufacturing and marketing of prescription pharmaceutical brands, surgical and medical devices. They are engaged in the manufacture of a wide range of pharmaceutical product through research and development and also in the manufacturing and marketing of diverse products through licensing agreements with international pharmaceutical companies. They are also engaged in the manufacturing of active pharmaceutical ingredients. Elder Pharmaceuticals Ltd was incorporated on April 2, 1983 in Maharashtra. The company started their commercial activities in the year 1988. In the year 1989, they commissioned their first factory in Navi Mumbai. The company was converted into a public limited company in August 1998. Over the years, the company launched the medicines either through their own research or through alliances with global companies.
The company entered into strategic alliances with a number of international pharmaceutical entities for marketing their products in India and overseas international acquisitions have strengthened and enabled the company to become a true-global pharmaceutical company. They made the tie up with Haw Par, Singapore during the year 1994 and Fujisawa during the year 1998. During the year 2000-01, the company entered into joint venture agreement with Stiefel Laboratories Inc. Also they made a tie up with Paul Hartmann of Germany for marketing their incotinence and wound healing in India. During the year 2002-03, the company made a tie up with an American company namely, Blistex Inc, for license manufacturing and distribution of their Lip Care products. The company entered into technical/ marketing collaborations with Covex and Ferrer of Spain for their products for Cognitive disorders, Cerebral strokes and Head injuries, Tanabe Seiyaku and Fujisawa of Japan for their products for Hypertension and Heart Failure and TRB Chemeica of Switzerland for their product for Osteoarthritis. During the same year, the company entered into new joint venture agreement with the Universal Group of Companies, Nepal for setting up a pharmaceutical formulations plant in Nepal. In March 2003, they started their operation in their Bulk Drug plant at Patalganga. During the year 2004-05, the company acquired an international brand 'Tobraneg' from Ely Lilly and company of USA at a price of Rs. 172.50 lakh. During the year 2005-06, they commissioned one of their new manufacturing units at Sela Qui in Uttarakhand, which is equipped to manufacture tablets and capsules. The company introduced 'Somazina', a neuroprotector during the year. During the year 2006-07, the company introduced Eldervit ZC, Redirinse, Nedge, Bonviva and Deviron in the market.
Also, they entered with the alliances with Roche of Switzerland for their product 'Bonivini', Daiwa of Japan for their product 'Biobran' & 'NKCP', Enzymotec of Isreal for their product 'Cardiabeat' and Almirall of Spain for the product 'Cinitapride'. The company commenced commercial production of manufacturing of topical formulation in their plant at Paonta Sahib in Himachal Pradesh during the year. They commissioned a betalactum plant in Nepal through a joint venture with Universal Pharmaceuticals. The company also entered into joint venture with Vincom Pharmaceuticals in Ghana for Oral Liquid dosages. In January 2007, the company established a wholly owned subsidiary, called Elder International FZCO in the Jebel Ali Free Trade Zone, Dubai. During the year 2007-08, the company got associated with Cymbiotics of California, USA for marketing six of their patented products for Diabetes, Chrobnic pain, Skin Care, etc. and Gnosis of Italy for marketing of 'Sampure'. They formed a wholly owned subsidiary in Cyprus by the name Somerta Holdings Co Ltd with a capital of Euro 5000. The company through their wholly owned subsidiary, Elder International FZCO acquired a 21% stake in Neutrahealth PLC, an AIM London Stock Exchange listed company and also established a wholly owned subsidiary in Bulgaria by the name 'Elder Biomeda EDA' with the object of acquiring 100% stake in three Biomeda Group companies for the total investment of Euro 3.12 million. The company was awarded Amity Corporate Excellence Award for the year 2008 and Frost & Sullivan Market Leadership Award for 'Shelcal' for the year 2008. They have been named in the Forbes list of 'Asia's 200 Best under a billion' over a period of three years. In November 2008, the company entered into a deal with Japan's Daiwa Pharmaceuticals Co Ltd for manufacturing and marketing of some of their products in India. Also, they acquired 100% stake in three Bulgarian pharma companies through their wholly owned Bulgarian subsidiary Elder Biomeda EAD.
According to the Consolidated - Audited financial statement for the Year of 2012, total net operating revenues increased with 53.12%, from INR 886.02 tens of millions to INR 1,356.66 tens of millions. Operating result increased from INR 170.56 tens of millions to INR 199.01 tens of millions which means 16.68% change. The results of the period increased 12.75% reaching INR 70.74 tens of millions at the end of the period against INR 62.74 tens of millions last year. Return on equity (Net income/Total equity) went from 10.30% to 10.10%, the Return On Asset (Net income / Total Asset) went from 3.60% to 3.93% and the Net Profit Margin (Net Income/Net Sales) went from 7.08% to 5.21% when compared to the same period of last year. The Debt to Equity Ratio (Total Liabilities/Equity) was 185.44% compared to 189.69% of last year.
( Equity Cash, Nse Fno Call, Jackpot call, Sure shot call, BTST/STBT call / Nifty Tips / Bank Nifty Tips)
Under one plan with Unbelievable Lowest price
for Free Trial Give a Miss Call on 9015611166 or visit A1 Intraday Tips
to Earn daily Rupees 10000 to 15000
Our all call under in one plan
(Equity Calls, Fno, Jackpot, Sure Shot, Nifty, Bank Nifty Tips)
Nse Listed Companies with Live Charts
with live charts starting with that Alphabet.)
| A | B | C | D | E | F | G | H | I | J |
| K | L | M | N | O | P | Q | R | S | T |
| U | V | W | X | Y | Z |
